Anixa Biosciences Inc — Director's Dealing 2011

Feb 10, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2011-02-08

Reporting Person: HERMS HENRY P (Director, Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-02-08	Common Stock	P	280000	$0.1786	Acquired	290575	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-02-08	Common Stock Purchase Warrants (Right to Buy)	$0.1786	P	280000	Acquired	2016-02-08	Common stock (280000)	Direct

Footnotes

F1: On February 8, 2011, Mr. Herms purchased 280,000 shares of Common Stock, par value $0.01 and 280,000 Warrants to purchase Common Stock for an aggregate purchase price of $50,000 from CopyTele, Inc. in a private placement.